-
公开(公告)号:US20210177895A1
公开(公告)日:2021-06-17
申请号:US17183593
申请日:2021-02-24
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Ido AMIT , Merav COHEN , Amir GILADI
IPC: A61K35/15 , C12N5/0787
Abstract: A method of treating a disease or disorder that can benefit from increasing an M2/M1 macrophage ratio in a subject in need thereof is provided. The method comprising: (a) culturing basophils in the presence of IL33 and/or GM-SCF; and (b) administering to the subject a therapeutically effective amount of the basophils following the culturing, thereby treating the disease or disorder that can benefit from increasing an M2/M1 macrophage ratio in the subject.
-
272.
公开(公告)号:US10995141B2
公开(公告)日:2021-05-04
申请号:US16852508
申请日:2020-04-19
Inventor: Ester Yoles , Berit Olsen Krogh , Allan Jensen , Jan Egebjerg , Carol David , Kuti Baruch , Michal Eisenbach-Schwartz
Abstract: The present specification discloses modified anti-PD-L1 antibodies that abolishes Fc-related effector function and enhances clearance rate while maintaining therapeutic efficacy for neurodegenerative disease modification. The present specification also discloses nucleic acid sequences and expression constructs encoding such modified anti-PD-L1 antibodies as well as methods of making such modified anti-PD-L1 antibodies. In addition, the present specification discloses methods of treatment and uses that employ an administration regime of the disclosed anti-PD-L1 antibodies that ensures the antibodies are present for only a specific period of time and then are sufficiently cleared from the body to ensure treatment efficacy is maintained.
-
273.
公开(公告)号:US10981989B2
公开(公告)日:2021-04-20
申请号:US16284081
申请日:2019-02-25
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Michal Eisenbach-Schwartz , Kuti Baruch , Neta Rosenzweig
IPC: A61K39/395 , C07K16/28 , A61K38/00 , A61K38/14 , A61K45/06 , A61K31/404 , A61K31/7068 , A61K33/36 , A61K38/16 , A61K38/18 , A61K38/20 , A61K31/4155 , A61K38/02 , A61K39/00
Abstract: A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS that does not include the autoimmune neuroinflammatory disease, relapsing-remitting multiple sclerosis (RRMS), is provided. The pharmaceutical composition is for administration by a dosage regimen comprising at least two courses of therapy, each course of therapy comprising in sequence a treatment session followed by an interval session of non-treatment.
-
公开(公告)号:US10933134B2
公开(公告)日:2021-03-02
申请号:US15924039
申请日:2018-03-16
Applicant: Memorial Sloan Kettering Cancer Center , Yeda Research and Development Co. Ltd., at the Weizmann Institute of Science
Inventor: Jonathan Coleman , Philip A. Watson , Kwanghee Kim , Avigdor Scherz
Abstract: A method for treatment of prostate cancer or benign prostate hyperplasia by combination therapy comprising administering to a patient an androgen-deprivation therapy agent and a bacteriochlorophyll derivative followed by photodynamic therapy (PDT) or vascular-targeted photodynamic therapy (VTP).
-
公开(公告)号:US20210052626A1
公开(公告)日:2021-02-25
申请号:US17089769
申请日:2020-11-05
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Idit SHACHAR , Hadas LEWINSKY , Lihi RADOMIR , Anna WIENER
Abstract: A method of treating a malignant disease involving T cell exhaustion in a subject, with the proviso that said malignant disease is not a B cell malignancy, is disclosed. The method comprising administering to the subject a therapeutically effective amount of an agent capable of decreasing an activity or expression of CD84, thereby treating the malignant disease involving the T cell exhaustion. Also disclosed is a method of treating an autoimmune or inflammatory disease in a subject, the method comprising administering to a subject a therapeutically effective amount of an agent capable of decreasing an activity or expression of CD84. A method comprising administering to the subject a therapeutically effective amount of an agent capable of decreasing an activity or expression of SLAMF1, with the proviso that said agent is not an agent capable of decreasing an activity or expression of CD84, is also disclosed.
-
公开(公告)号:US20210046271A1
公开(公告)日:2021-02-18
申请号:US17083493
申请日:2020-10-29
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Noam SOBEL , Ethan LIVNE , Aharon WEISSBROD , Sagit SHUSHAN , Danielle Ricca HONIGSTEIN
Abstract: A nasal cannula includes a prong formed from an inner cylindrical wall surrounded by an outer cylindrical wall, a base connecting the inner cylindrical wall to the outer cylindrical wall and an air channel formed between the inner and outer cylindrical wall. The inner cylindrical wall defines a bore through which air may freely flow. The nasal cannula additional includes a connector fluidly connected to the air channel and configured to provide flow communication between the air channel and an external device connected to the connector.
-
公开(公告)号:US20210038166A1
公开(公告)日:2021-02-11
申请号:US16985375
申请日:2020-08-05
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Eran SEGAL , Smadar SHILO , Hagai ROSSMAN
Abstract: A method of predicting likelihood for childhood obesity, comprises: obtaining a plurality of parameters, wherein at least a few of the parameters characterize an infant or toddler subject. A machine learning procedure trained for predicting likelihoods for childhood obesity is feed with the plurality of parameters. An output indicative of a likelihood that the infant or toddler subject is expected to develop childhood obesity is received from the procedure. The output is related non-linearly to the parameters.
-
公开(公告)号:US20210007363A1
公开(公告)日:2021-01-14
申请号:US17040227
申请日:2019-03-21
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD
Inventor: Asaph AHARONI , Elisa KORENBLUM
IPC: A01N63/38 , C07D305/14 , C07J17/00 , A01N63/20 , A01G29/00
Abstract: Provided is a plant exudate, methods for obtaining a plant exudate by inducing the plant to secrete an exudate and systems for the collection of a plant exudate which include: one or more plant container including at least two discrete compartments each configured to accommodate a split root of a plant, the compartments being a root stimulating compartment including one or more input being in fluid communication with at least a source of a plant root stimulant, and a root exudate harvesting compartment, and a root exudate collection compartment in fluid communication with the root exudate harvesting compartment.
-
公开(公告)号:US20200380960A1
公开(公告)日:2020-12-03
申请号:US16767110
申请日:2018-11-26
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Elisha MOSES , Tirza BIRON , Dominik FRECHE , Daniel BAUM , Nadav MATALON , Netanel EHRMANN , Eyal WEINREB
Abstract: A prosodic speech recognition engine configured to identify prosodic features and patterns in a speech continuum for the extraction of linguistic content including para-syntactic content, discourse function, information structure, meaning, and speaker sentiment.
-
公开(公告)号:US20200378752A1
公开(公告)日:2020-12-03
申请号:US16071089
申请日:2017-01-19
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Igor LUBOMIRSKY , Guy LAZOVSKI
Abstract: Methods, devices and apparatus for measuring expansion/contraction properties of a material are described. According to an embodiment a method comprises: providing a device, said device comprising a sample comprising said material, said sample comprising a first surface and a second surface, a first substrate and a second substrate connected to said first surface and to said second surface of said sample, respectively, a reflective material attached to said second substrate, and two electrical contacts each independently in contact with said sample; applying voltage to said sample using said electrical contacts; illuminating said reflective material using a light source, such that said illumination comprises light having known and controllable polarization; collecting light reflected off said reflective material; measuring amplitude and phase of an oscillating change in polarization of the reflected light; and extracting parameters related to expansion/contraction from said reflected light measurement, thus evaluating said expansion/contraction properties of said material.
-
-
-
-
-
-
-
-
-